Abstract

Digital pathology represents a major evolution in modern medicine. Pathological examinations constitute the standard in medical protocols and the law, and call for specific action in the diagnostic process. Advances in digital pathology have made it possible for image analysis to take advantage of the information analysis from hematoxylin and eosin stained images. In spite of concern, it is recorded in the majority of breast cancer datasets, which makes research more difficult in prediction. The objective of our work is to evaluate the performance of the machine learning and deep learning techniques applied to predict breast cancer recurrence rates. This study starts with an overview of tissue preparation, analysis of stained images, and a prognosis for cancer patients. The high accuracy results recorded are compromised in terms of sensitivity and specificity. The missing loss function and class imbalance problems are rarely addressed, and most often the chosen performance measures are context-inappropriate. The challenge that presents itself is to analyse whole slide images for the content imaging required with diagnostic biomarkers, and prognosis support backed by digital pathology.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.